142 related articles for article (PubMed ID: 11113544)
41. Effects of individual and concurrent stimulation of striatal D1 and D2 dopamine receptors on electrophysiological and behavioral output from rat basal ganglia.
Waszczak BL; Martin LP; Finlay HE; Zahr N; Stellar JR
J Pharmacol Exp Ther; 2002 Mar; 300(3):850-61. PubMed ID: 11861790
[TBL] [Abstract][Full Text] [Related]
42. Activation of dopamine D2 receptors decreases DARPP-32 phosphorylation in striatonigral and striatopallidal projection neurons via different mechanisms.
Lindskog M; Svenningsson P; Fredholm BB; Greengard P; Fisone G
Neuroscience; 1999; 88(4):1005-8. PubMed ID: 10336115
[TBL] [Abstract][Full Text] [Related]
43. Sensitization of amphetamine-induced stereotyped behaviors during the acute response: role of D1 and D2 dopamine receptors.
Kuczenski R; Segal DS
Brain Res; 1999 Mar; 822(1-2):164-74. PubMed ID: 10082894
[TBL] [Abstract][Full Text] [Related]
44. Involvement of dopamine receptors of the dorsal hippocampus on the acquisition and expression of morphine-induced place preference in rats.
Rezayof A; Zarrindast MR; Sahraei H; Haeri-Rohani A
J Psychopharmacol; 2003 Dec; 17(4):415-23. PubMed ID: 14870954
[TBL] [Abstract][Full Text] [Related]
45. Dopamine-opioid interactions in the rat striatum: a modulatory role for dopamine D1 receptors in delta opioid receptor-mediated signal transduction.
Unterwald EM; Cuntapay M
Neuropharmacology; 2000 Jan; 39(3):372-81. PubMed ID: 10698003
[TBL] [Abstract][Full Text] [Related]
46. D1 dopamine receptor activity of anti-parkinsonian drugs.
Fici GJ; Wu H; VonVoigtlander PF; Sethy VH
Life Sci; 1997; 60(18):1597-603. PubMed ID: 9126882
[TBL] [Abstract][Full Text] [Related]
47. Effects of intrasubthalamic injection of dopamine receptor agonists on subthalamic neurons in normal and 6-hydroxydopamine-lesioned rats: an electrophysiological and c-Fos study.
Hassani OK; Féger J
Neuroscience; 1999; 92(2):533-43. PubMed ID: 10408602
[TBL] [Abstract][Full Text] [Related]
48. A mechanism underlying dopamine D1 and D2 receptor-mediated inhibition of dopaminergic neurones in the ventral tegmental area in vitro.
Momiyama T; Todo N; Sasa M
Br J Pharmacol; 1993 Aug; 109(4):933-40. PubMed ID: 8104652
[TBL] [Abstract][Full Text] [Related]
49. Transcriptional activation of phosphodiesterase 7B1 by dopamine D1 receptor stimulation through the cyclic AMP/cyclic AMP-dependent protein kinase/cyclic AMP-response element binding protein pathway in primary striatal neurons.
Sasaki T; Kotera J; Omori K
J Neurochem; 2004 Apr; 89(2):474-83. PubMed ID: 15056290
[TBL] [Abstract][Full Text] [Related]
50. Regulation of dopamine receptors and motor behavior following pulsatile and continuous dopaminergic replacement strategies in the MPTP primate model.
Blanchet PJ; Calon F; Morissette M; Goulet M; Grondin R; Lévesque D; Bédard PJ; Di Paolo T
Adv Neurol; 2001; 86():337-44. PubMed ID: 11553994
[No Abstract] [Full Text] [Related]
51. 6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons.
Cole DG; Kobierski LA; Konradi C; Hyman SE
Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9631-5. PubMed ID: 7937819
[TBL] [Abstract][Full Text] [Related]
52. The dopamine D1 receptor antagonist SCH 23390 can exert D1 agonist-like effects on rat nucleus accumbens neurons.
Wachtel SR; White FJ
Neurosci Lett; 1995 Oct; 199(1):13-6. PubMed ID: 8584215
[TBL] [Abstract][Full Text] [Related]
53. Differential regulation of NF-kappaB, SRE and CRE by dopamine D1 and D2 receptors in transfected NG108-15 cells.
Takeuchi Y; Fukunaga K
J Neurochem; 2003 May; 85(3):729-39. PubMed ID: 12694399
[TBL] [Abstract][Full Text] [Related]
54. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
Engber TM; Marin C; Susel Z; Chase TN
Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970
[TBL] [Abstract][Full Text] [Related]
55. Two intracellular signaling pathways for the dopamine D3 receptor: opposite and synergistic interactions with cyclic AMP.
Griffon N; Pilon C; Sautel F; Schwartz JC; Sokoloff P
J Neurochem; 1997 Jan; 68(1):1-9. PubMed ID: 8978703
[TBL] [Abstract][Full Text] [Related]
56. Dopamine D1/D2 agonists injected into nucleus accumbens and ventral pallidum differentially affect locomotor activity depending on site.
Gong W; Neill DB; Lynn M; Justice JB
Neuroscience; 1999; 93(4):1349-58. PubMed ID: 10501459
[TBL] [Abstract][Full Text] [Related]
57. Apomorphine induces trophic factors that support fetal rat mesencephalic dopaminergic neurons in cultures.
Guo H; Tang Z; Yu Y; Xu L; Jin G; Zhou J
Eur J Neurosci; 2002 Nov; 16(10):1861-70. PubMed ID: 12453049
[TBL] [Abstract][Full Text] [Related]
58. Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum.
Aubert I; Ghorayeb I; Normand E; Bloch B
J Comp Neurol; 2000 Feb; 418(1):22-32. PubMed ID: 10701753
[TBL] [Abstract][Full Text] [Related]
59. Evidence of increased dopamine receptor signaling in food-restricted rats.
Carr KD; Tsimberg Y; Berman Y; Yamamoto N
Neuroscience; 2003; 119(4):1157-67. PubMed ID: 12831870
[TBL] [Abstract][Full Text] [Related]
60. Multisecond oscillations in firing rate in the globus pallidus: synergistic modulation by D1 and D2 dopamine receptors.
Ruskin DN; Bergstrom DA; Walters JR
J Pharmacol Exp Ther; 1999 Sep; 290(3):1493-501. PubMed ID: 10454529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
